Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00779324 · ClinicalTrials.gov registry record · NA
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 168
- Enrollment target
NCT00779324 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 168 participants.
The verdict
NCT00779324, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
Study Summary
The purpose of this study is to study the effect of amantadine on irritability and aggression caused by traumatic brain injury.
Interventions
- DRUG Placebo
- DRUG Amantadine Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2009-08 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00779324
The ClinicalTrials.gov registry entry for NCT00779324 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00779324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00779324 about?
NCT00779324 is a clinical study titled "Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study". The purpose of this study is to study the effect of amantadine on irritability and aggression caused by traumatic brain injury.
What is the current status of trial NCT00779324?
This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2009-08. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00779324?
The interventions under investigation include: Placebo (DRUG), Amantadine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00779324?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.